Radiation-induced fatigue and prostate cancer management

One of the annoyances associated with radiation treatments given over a long duration (for prostate cancer and for other reasons) is a growing feeling of fatigue. … READ MORE …

Muscle mass and fatigue in men with advanced prostate cancer

A newly published study from a Dutch research group has suggested that higher muscle mass is associated with less risk for fatigue in men with advanced prostate cancer. … READ MORE …

Provigil does NOT alleviate fatigue in most patients treated with docetaxel chemotherapy

It has been suggested on and off that taking a drug called modafinil (Provigil) with chemotherapy can help to alleviate the tiredness and fatigue felt by some patients who are receiving docetaxel-based chemotherapy (for prostate cancer and for other forms of cancer). … READ MORE …

Abiraterone acetate treatment affects fatigue in men with mCRPC

According to a retrospective analysis of data from a randomized, double-blind, Phase III clinical trial, abiraterone acetate (Zytiga™) can significantly lower levels of fatigue in men with metastatic, castration-resistant prostate cancer (as well extending survival). … READ MORE …

Chronic fatigue after first-line therapy for localized prostate cancer

There are few good data on the occurrence of chronic fatigue after first-line treatment of localized prostate cancer. … READ MORE …

The latest word from Dana

This week Dana Jennings writes about the fatigue that he and many men with more advanced forms of prostate cancer feel — from the cancer itself and also from the treatments needed to keep it under as much control as possible.

The Saturday prostate cancer post: November 1, 2008

There are a lot of news items this weekend. This first batch addresses studies on:

  • The incidence of clinically insignificant prostate cancer
  • Bladder and rectal cancers as side effects of radiotherapy for management of localized prostate cancer.
  • Fatigue in cancer patients in general (and prostate cancer therapy specifically).
  • The appropriate use of androgen deprivation therapy
  • Second line chemotherapy for castration-resistant prostate cancer. … READ MORE …>